Impact of treatment on resting cerebral blood flow and metabolism in obsessive compulsive disorder: a meta-analysis
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Neurobiological models of obsessive-compulsive disorder (OCD) posit that its clinical symptoms such as repetitive thoughts and behaviors are related to hyperactivity in the cortico–striato–thalamo–cortical (CSTC) circuit. Small scale neuroimaging studies have shown that treatment of OCD is associated with reduced activity across different brain structures within this circuitry. We performed the first meta-analysis of positron emission tomography (PET) and single photon emission computed tomography (SPECT) studies that investigated cerebral blood flow or glucose metabolism in patients with OCD before and after pharmacological or psychological treatment. We calculated standardized mean differences for the regions-of-interest most often reported. The meta-analysis revealed small reductions in activity in the caudate nucleus and orbitofrontal cortex after treatment with a serotonin reuptake inhibitor or cognitive behavioral therapy. Small reductions were also observed in the thalamus when one SPECT study with a large opposite effect was excluded from the analysis. Meta-regression analyses for the caudate nucleus showed no significant effect of the type of treatment, decrease in symptom severity, mean duration until the follow-up scan, or year of publication. These results show that pharmacological and psychological treatments reduce resting CSTC circuit activity, and provide further support for the CSTC circuit model in OCD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Yale-Brown Obsessive Compulsive Scale: II. Validity
Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110054008 · Cited by 2,799 · cited 1×
“In addition, we performed a random-effect meta-regression33 to determine (1) the differences between treatment with medication and with CBT; (2) the influence of reduction in YBOCS score; (3) the influence of the mean duration until the follow-up scan; (4) the influence of the date of publication.”
MethodThe epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication
Ruscio, A. M., Stein, D. J., Chiu, W. T., & Kessler, R. C. (2010) · Molecular Psychiatry · doi:10.1038/mp.2008.94 · Cited by 2,771 · cited 1×
“In addition, we performed a random-effect meta-regression33 to determine (1) the differences between treatment with medication and with CBT; (2) the influence of reduction in YBOCS score; (3) the influence of the mean duration until the follow-up scan; (4) the influence of the date of publication.”
MethodHow Many Studies Do You Need?: A Primer on Statistical Power for Meta-Analysis
Valentine, J. C., Pigott, T. D., & Rothstein, H. R. (2010) · Journal of Educational and Behavioral Statistics · doi:10.3102/1076998609346961 · Cited by 1,294
Baxter, L. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820090009002 · Cited by 1,293
Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder
(2008) · APA Practice Guidelines for the Treatment of Psychiatric Disorders: Comprehensive Guidelines and Guideline Watches · doi:10.1176/appi.books.9780890423363.149114 · Cited by 1,028 · cited 1×
“In addition, we performed a random-effect meta-regression33 to determine (1) the differences between treatment with medication and with CBT; (2) the influence of reduction in YBOCS score; (3) the influence of the mean duration until the follow-up scan; (4) the influence of the date of publication.”
MethodObsessive-compulsive disorder: An integrative genetic and neurobiological perspective
Pauls, D. L., Abramovitch, A., Rauch, S. L., & Geller, D. A. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3746 · Cited by 793
A meta-analysis of functional neuroimaging in obsessive-compulsive disorder
Whiteside, S. P., Port, J. D., & Abramowitz, J. S. (2004) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2004.07.001 · Cited by 520
Saxena, S. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00082-2 · Cited by 379
Brain circuitry of compulsivity
van den Heuvel, O. A., van Wingen, G., Soriano-Mas, C., Alonso, P., Chamberlain, S. R., Nakamae, T., Denys, D., Goudriaan, A. E., & Veltman, D. J. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.12.005 · Cited by 374 · cited 1×
“In addition, we performed a random-effect meta-regression33 to determine (1) the differences between treatment with medication and with CBT; (2) the influence of reduction in YBOCS score; (3) the influence of the mean duration until the follow-up scan; (4) the influence of the date of publication.”
MethodSelf-citationPathophysiology of obsessive–compulsive disorder
Aouizerate, B., Guehl, D., Cuny, E., Rougier, A., Bioulac, B., Tignol, J., & Burbaud, P. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.02.004 · Cited by 341
Research works printed but not linked: 33
- Benkelfat, C. et al. Local cerebral glucose metabolic rates in obsessive-compulsive disorder. Patients treated with clomipramine. Arch Gen Psychiatry 47, 840–848 (1990). · DOI · Paper page
- Schwartz, J. M. et al. Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. Arch Gen Psychiatry 53, 109–113 (1996). · DOI · Paper page
- Hansen, E. S., Hasselbalch, S., Law, I. & Bolwig, T. G. The caudate nucleus in obsessive-compulsive disorder. Reduced metabolism following treatment with paroxetine: a PET study. Int J Neuropsychopharmacol 5, 1–10, https://doi.org/10.1017/S1461145701002681 (2002). · DOI · Paper page
- Swedo, S. E. et al. Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Revisualization during pharmacotherapy. Arch Gen Psychiatry 49, 690–694 (1992). · DOI · Paper page
- Perani, D. et al. [18F]FDG PET study in obsessive-compulsive disorder. A clinical/metabolic correlation study after treatment. The British journal of psychiatry: the journal of mental science 166, 244–250 (1995). · DOI · Paper page
- Saxena, S. et al. Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression. Arch Gen Psychiatry 59, 250–261 (2002). · DOI · Paper page
- Apostolova, I. et al. Effects of behavioral therapy or pharmacotherapy on brain glucose metabolism in subjects with obsessive-compulsive disorder as assessed by brain FDG PET. Psychiatry Res 184, 105–116, https://doi.org/10.1016/j.pscychresns.2010.08.012 (2010). · DOI
- Yamanishi, T. et al. Changes after behavior therapy among responsive and nonresponsive patients with obsessive-compulsive disorder. Psychiatry Res 172, 242–250, https://doi.org/10.1016/j.pscychresns.2008.07.004 (2009). · DOI
- Nakatani, E. et al. Effects of behavior therapy on regional cerebral blood flow in obsessive-compulsive disorder. Psychiatry Res 124, 113–120 (2003). · DOI
- Ho Pian, K. L. et al. Decreased thalamic blood flow in obsessive-compulsive disorder patients responding to fluvoxamine. Psychiatry Res 138, 89–97, https://doi.org/10.1016/j.pscychresns.2004.12.003 (2005). · DOI
- Hoehn-Saric, R., Pearlson, G. D., Harris, G. J., Machlin, S. R. & Camargo, E. E. Effects of fluoxetine on regional cerebral blood flow in obsessive-compulsive patients. Am J Psychiatry 148, 1243–1245, https://doi.org/10.1176/ajp.148.9.1243 (1991). · DOI · Paper page
- Rubin, R. T., Ananth, J., Villanueva-Meyer, J., Trajmar, P. G. & Mena, I. Regional 133xenon cerebral blood flow and cerebral 99mTc-HMPAO uptake in patients with obsessive-compulsive disorder before and during treatment. Biol Psychiatry 38, 429–437 (1995). · DOI
- Karadag, F. et al. The comparison of pre- and post-treatment (99m)Tc HMPAO brain SPECT images in patients with obsessive-compulsive disorder. Psychiatry Res 213, 169–177, https://doi.org/10.1016/j.pscychresns.2012.07.005 (2013). · DOI
- Hedges, L. V. & Olkin, I. Statistical methods for meta-analysis (Academic Press, 1985).
- Cohen, J. Statistical Power Analysis for the Behavioral Sciences (Routledge Academic, 1988).
- Holm, S. A Simple Sequentially Rejective Multiple Test Procedure. Scandinavian Journal of Statistics 6, 65–70 (1979).
- Deutsch, G., Mountz, J. M., Katholi, C. R., Liu, H. G. & Harrell, L. E. Regional stability of cerebral blood flow measured by repeated technetium-99m-HMPAO SPECT: implications for the study of state-dependent change. J Nucl Med 38, 6–13 (1997).
- Holcomb, H. H. et al. PET-FDG test-retest reliability during a visual discrimination task in schizophrenia. J Comput Assist Tomogr 17, 704–709 (1993). · DOI
- Bartlett, E. J. et al. Reproducibility of cerebral glucose metabolic measurements in resting human subjects. J Cereb Blood Flow Metab 8, 502–512, https://doi.org/10.1038/jcbfm.1988.91 (1988). · DOI · Paper page
- Higgins, J. P., Thompson, S. G., Deeks, J. J. & Altman, D. G. Measuring inconsistency in meta-analyses. BMJ 327, 557–560, https://doi.org/10.1136/bmj.327.7414.557 (2003). · DOI · Paper page
- Aylward, E. H. et al. Normal caudate nucleus in obsessive-compulsive disorder assessed by quantitative neuroimaging. Arch Gen Psychiat 53, 577–584 (1996). · DOI · Paper page
- Egger, M., Davey Smith, G., Schneider, M. & Minder, C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629–634 (1997). · DOI · Paper page
- Berkey, C. S., Hoaglin, D. C., Mosteller, F. & Colditz, G. A. A random-effects regression model for meta-analysis. Stat Med 14, 395–411 (1995). · DOI · Paper page
- Thompson, S. G. & Higgins, J. P. How should meta-regression analyses be undertaken and interpreted? Stat Med 21, 1559–1573, https://doi.org/10.1002/sim.1187 (2002). · DOI · Paper page
- Kang, D. H. et al. Brain glucose metabolic changes associated with neuropsychological improvements after 4 months of treatment in patients with obsessive-compulsive disorder. Acta Psychiatr Scand 107, 291–297 (2003). · DOI · Paper page
- Hendler, T. et al. Brain reactivity to specific symptom provocation indicates prospective therapeutic outcome in OCD. Psychiatry Res 124, 87–103 (2003). · DOI
- Carey, P. D. et al. Single photon emission computed tomography (SPECT) of anxiety disorders before and after treatment with citalopram. BMC Psychiatry 4, 30, https://doi.org/10.1186/1471-244X-4-30 (2004). · DOI · Paper page
- Molina, V. et al. Drug therapy and cerebral perfusion in obsessive-compulsive disorder. J Nucl Med 36, 2234–2238 (1995).
- Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G. & Group, P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6, e1000097, https://doi.org/10.1371/journal.pmed.1000097 (2009). · DOI · Paper page
- Saxena, S. et al. Rapid effects of brief intensive cognitive-behavioral therapy on brain glucose metabolism in obsessive-compulsive disorder. Mol Psychiatry 14, 197–205, https://doi.org/10.1038/sj.mp.4002134 (2009). · DOI · Paper page
- Ginsberg, M. D. et al. Increases in both cerebral glucose utilization and blood flow during execution of a somatosensory task. Ann Neurol 23, 152–160, https://doi.org/10.1002/ana.410230208 (1988). · DOI · Paper page
- Conca, A. et al. Preliminary findings of simultaneous 18F-FDG and 99mTc-HMPAO SPECT in patients with depressive disorders at rest: differential correlates with ratings of anxiety. Psychiatry Res 98, 43–54 (2000). · DOI
- Dunn, R. T. et al. Preliminary findings of uncoupling of flow and metabolism in unipolar compared with bipolar affective illness and normal controls. Psychiatry Res 140, 181–198, https://doi.org/10.1016/j.pscychresns.2005.07.005 (2005). · DOI
Cited by
Ahmari, S. E., & Rauch, S. L. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-021-01130-2 · Cited by 95
Bruin, W. B., Abe, Y., Alonso, P., Anticevic, A., Backhausen, L. L., Balachander, S., Bargallo, N., Batistuzzo, M. C., Benedetti, F., Bertolin Triquell, S., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02077-0 · Cited by 81
Self-citationManning, E. E., Dombrovski, A. Y., Torregrossa, M. M., & Ahmari, S. E. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-018-0307-2 · Cited by 79
Neuromodulation of OCD: a review of invasive and non-invasive methods
Kammen, A., Cavaleri, J., Lam, J., Frank, A. C., Mason, X., Choi, W., Penn, M., Brasfield, K., Van Noppen, B., Murray, S. B., et al. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.909264 · Cited by 38
“Interestingly, successful pharmacological or psychological treatment of OCD leads to normalization of OFC and caudate nucleus activity, again supporting a hypothesis that these structures are involved in the pathogenesis of OCD symptoms (18).”
BackgroundKim, M., Kwak, S., Yoon, Y. B., Kwak, Y. B., Kim, T., Cho, K. I. K., Lee, T. Y., & Kwon, J. S. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0436-2 · Cited by 37
Metadata
- Authors
- van der Straten, A. L., Denys, D., & van Wingen, G. A.
- Venue
- Scientific Reports
- Published
- 2017-12-12
- Volume
- 7
- Issue
- 1
- Pages
- 17464-17464
- ISSN
- 2045-2322 (ISSN-L)
- OpenAlex
- W2774876719
- Cited by
- 44
- References
- 12
- FWCI
- 0.97
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impact of treatment on resting cerebral blood flow and metabolism in obsessive compulsive disorder: a meta-analysis. https://app.cochat.ai/papers/10.1038/s41598-017-17593-7
- The paper
- van der Straten, A. L., Denys, D., & van Wingen, G. A. (2017). Impact of treatment on resting cerebral blood flow and metabolism in obsessive compulsive disorder: a meta-analysis. Scientific Reports. https://doi.org/10.1038/s41598-017-17593-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.